Michael Mollerus

Davis Polk advised the joint book-running managers in connection with an offering by Eastman Chemical Company of €200 million aggregate principal amount of its 1.50% notes due 2023 and €500…

Davis Polk advised the dealer managers on a cash tender offer by Honeywell International Inc. for any and all of its 5.30% senior notes due 2017, 5.30% senior notes due 2018 and 5.00%…

Davis Polk advised the underwriters in connection with a public offering by International Business Machines Corporation of ¥42 billion principal amount of its 0.30% notes due 2026. The…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Honeywell International Inc. of $1.25 billion aggregate principal amount of its 1.400%…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering of $400 million aggregate principal amount of Callon Petroleum Company’s 6.125% senior…

Davis Polk advised AC Immune SA in connection with its $75.9 million U.S. initial public offering. AC Immune sold 6,900,000 of its common shares in the offering, which included 900,000…

Davis Polk advised Shire plc on the $12.1 billion SEC-registered debt offering by its wholly owned subsidiary, Shire Acquisitions Investments Ireland DAC (“SAIIDAC”), consisting of $3.3…

Davis Polk advised Delphi Automotive PLC in connection with a SEC-registered offering of $300 million aggregate principal amount of its 4.400% senior notes due 2046. The notes are…

Davis Polk advised Delphi Automotive PLC in connection with an SEC-registered offering of €500 million aggregate principal amount of its 1.600% senior notes due 2028. The notes are…

Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 29,900,000 shares of common stock of Callon Petroleum Company (“Callon”). The…